Skip to main content
DNA Labs India

MYH9 Gene Deafness, autosomal dominant type 17 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

MYH9 Gene Deafness, autosomal dominant type 17 NGS Genetic Test

Short Name: MYH9 DFNA17 NGS Test

Also known as: DFNA17, MYH9-related hereditary hearing loss

MYH9 Gene Deafness, autosomal dominant type 17 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks from sample receipt. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

To identify mutations in the MYH9 gene responsible for autosomal dominant deafness type 17 (DFNA17), aiding in diagnosis, prognosis, and family risk assessment.

Test Code
2296
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 weeks from sample receipt
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation required. Provide detailed clinical and family history.

Method: Venipuncture

Step 2

Laboratory Analysis

Blood sample collected via venipuncture; alternatively, DNA extract or FTA card sample.

Step 3

Report Delivery

Apply pressure to puncture site; sample sent to lab for analysis.

Timeline: 3 to 4 weeks from sample receipt

Patient Instructions

1
Before the Test:Review patient history and obtain informed consent. A genetic counseling session is advised to draw a pedigree chart.
2
During the Test:Sample collection and processing per standard protocols.
3
After the Test:Report delivered in 3-4 weeks; follow-up counseling recommended for result interpretation.

About This Test

Who Should Get This Test

To identify mutations in the MYH9 gene responsible for autosomal dominant deafness type 17 (DFNA17), aiding in diagnosis, prognosis, and family risk assessment.

How to Prepare

  • Ensure proper labeling and documentation
  • Use aseptic technique
  • Store samples at ambient temperature if on FTA card

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"This genetic test is vital for early diagnosis and family planning in hereditary hearing loss cases."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume3-5 ml blood
ContainerEDTA tube or FTA card
Collection MethodVenipuncture

Sample Stability

Blood in EDTA: stable for 7 days at 2-8°C
FTA card: stable at room temperature for years
Sample Rejection Criteria:
  • Hemolyzed or clotted samples
  • Insufficient sample volume
  • Incorrect labeling or documentation

Understanding Your Results

Results indicate the presence or absence of mutations in the MYH9 gene. Positive findings confirm DFNA17, while negative results do not rule out other genetic causes.
📊

Pathogenic variant detected

Confirms diagnosis of DFNA17; genetic counseling recommended.

📊

No pathogenic variant detected

DFNA17 unlikely; consider other genetic or non-genetic causes.

📊

Variant of uncertain significance

Requires further evaluation and family studies.

⚠️ When to Consult a Doctor:

Consult a healthcare professional if you experience progressive hearing loss, have a family history of deafness, or need guidance on test results and management.

Limitations

  • Does not detect all genetic causes of hearing loss
  • May identify variants of uncertain significance
  • Requires genetic counseling for interpretation

Risks & Considerations

  • Minimal risks from blood draw: bruising, infection
  • Potential psychological impact of genetic results

Interfering Factors

  • Contaminated or degraded DNA sample
  • Recent blood transfusion
  • Improper sample storage or handling

Compare With Similar Tests

TestMYH9 Gene Deafness, autosomal dominant type 17 NGS Genetic TestGJB2 Gene Deafness NGS TestComprehensive Hearing Loss Gene PanelMitochondrial DNA SequencingSLC26A4 Gene Test
ComparisonMYH9 Gene Deafness, autosomal dominant type 17 NGS Genetic Test

Frequently Asked Questions

What is MYH9 Gene Deafness?
It is a genetic condition called autosomal dominant type 17 (DFNA17) causing progressive hearing loss due to MYH9 gene mutations.
Who should consider this test?
Individuals with progressive hearing loss, family history of deafness, or symptoms like tinnitus.
How is the test performed?
Using Next-Generation Sequencing (NGS) on a blood or DNA sample to analyze the MYH9 gene.
What does a positive result mean?
It confirms a diagnosis of DFNA17, guiding management and family risk assessment.
Is the test painful?
No, it involves a standard blood draw with minimal discomfort.
Can children take this test?
Yes, it is suitable for all ages with appropriate consent.
How accurate is NGS testing?
NGS is highly accurate for detecting genetic mutations, with over 99% coverage.
What if the result is negative?
DFNA17 is unlikely, but other causes should be evaluated by a healthcare professional.
Is home sample collection available?
Yes, free home collection is offered in many cities across India.
How long does it take to get results?
Reports are typically delivered in 3 to 4 weeks.
Is genetic counseling provided?
Yes, a genetic counseling session is recommended before and after testing.
Can this test detect other hearing loss genes?
No, it specifically targets the MYH9 gene; for broader analysis, consider a gene panel.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.